iRhythm earns FDA nod for changes to Zio AT following warning letter - MassDevice

Retrieved on: 2024-10-21 20:39:41

Tags for this article:

Click the tags to see associated articles and topics

iRhythm earns FDA nod for changes to Zio AT following warning letter - MassDevice. View article details on hiswai:

Excerpt

iRhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance related to design changes made to its Zio AT device.

Article found on: www.massdevice.com